AFT first-half net profit fell 66%, even as sales lifted 18%

AFT first-half net profit fell 66%, even as sales lifted 18%
Chair David Flacks said it's appropriate to invest more to spur growth. (Image: Supplied)
Jenny Ruth
AFT Pharmaceuticals' first-half net profit fell by 66% despite a more than 18% jump in revenue and a 30% growth in product sales and royalties, and it downgraded guidance for the full year.AFT also downgraded guidance provided in May and now expected operating profit of between $18 million and $23m for the full year ending March 2023, down from between $27m to $32m, saying that reflected growth investments and deferred license income due to the delay in Maxigesic IV getting US registration.However, the company is still expecting to pay a ma...

More Markets

NZ sharemarket flat despite export growth
Markets Market close

NZ sharemarket flat despite export growth

The NZ sharemarket dipped as Fletcher Building shares fell further.

Tom Raynel 25 Jun 2025
FMA to focus on private market offers
Markets

FMA to focus on private market offers

The FMA is worried about unsophisticated investors taking the bait.

Pattrick Smellie 25 Jun 2025
Xero splashes $4.1b for 'step-change' US acquisition
Markets

Xero splashes $4.1b for 'step-change' US acquisition

Buying Melio gives Xero a leg-up in the crucial US SME market.

Pattrick Smellie 25 Jun 2025
Chorus broadband expansion makes priority list
Infrastructure

Chorus broadband expansion makes priority list

Chorus claims $17 billion NZ Inc gain for a $3b spend.

Pattrick Smellie 25 Jun 2025